COVID-19 Research and Drug Development at Saint Louis University

May 21, 2020, 4:00 pm — 4:45 pm

Due to the COVID-19 outbreak, Precision Medicine Thursdays at Venture Café have moved to Zoom.

Join Zoom Meeting: https://venturecafestl.org/thisweek

The Institute of Clinical and Translational Sciences (ICTS), in collaboration with Venture Café, is hosting Precision Medicine Series on the third Thursday of every month! This month at ICTS Precision Medicine Thursday, join us to hear two researchers from Saint Louis University School of Medicine, John E. Tavis, PhD, Professor of Molecular Microbiology and Immunology, and Amelia K. Pinto, PhD, Assistant Professor of Molecular Microbiology and Immunology. Learn what is being done locally to address COVID-19!

Join us virtually this month to hear Saint Louis University researchers discuss the complexities of designing and testing drugs during the COVID-19 pandemic and the promising COVID-19 research underway at Saint Louis University. Dr. John E. Tavis will discuss the scientific, regulatory, and ethical challenges of developing drugs to address the COVID-19 pandemic. Dr. Amelia K. Pinto will speak about the COVID-19 research being done at Saint Louis University including both cell culture and animal model work being done in her lab, the Remdesivir clinical trial for which SLU was one site, and upcoming vaccine clinical trials that will be done in SLU’s Center for Vaccine Development.

For more information, please contact Tricia Salyer, Precision Medicine Navigator at ICTS, at salyerp@wustl.edu.